Skip to main content
Login
Contact
Subscribe
Search form
Search
The Kane Republican
Home
Forms
News
Sports
Classifieds
Obituaries
Entertainment
Special Sections
Talking About...
Photos
Videos
Games
Community Links
KADC
Kane Area High School
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Agios Pharmaceuticals
(NQ:
AGIO
)
47.75
USD
+1.79 (+3.89%)
Official Closing Price
Updated: 5:00 PM EST, Jan 21, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Agios Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Agios Presents Final Data from Phase 3 ClarIDHy Study of TIBSOVO® (ivosidenib tablets) in Patients with Previously Treated IDH1-Mutant Cholangiocarcinoma
January 17, 2021
– Supplemental New Drug Application Planned for Submission in Q1 2021 –
From
GlobeNewswire News Releases
Interesting AGIO Put And Call Options For March 19th
January 15, 2021
Investors in Agios Pharmaceuticals Inc (AGIO) saw new options begin trading this week, for the March 19th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the AGIO...
Tags
Stocks
From
Market News Video
The Daily Biotech Pulse: DBV's Positive FDA Feedback, Pfizer's Cancer Drug Gets Label Expansion, Applied DNA COVID Testing Volume Surges
January 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ...
Tags
Small Cap
AGIO
PFE
From
Benzinga
Noteworthy ETF Outflows: XBI, NTLA, AGIO, SAGE
January 14, 2021
Symbols mentioned in this story: XBI, NTLA, AGIO, SAGE Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Agios Highlights 2021 Milestones to Accelerate and Expand Its Genetically Defined Disease Portfolio and Drive Near- and Long-Term Value Creation
January 11, 2021
From
GlobeNewswire News Releases
Notable ETF Outflow Detected - XBI, AGIO, SAGE, IONS
January 05, 2021
Symbols mentioned in this story: XBI, AGIO, SAGE, IONS Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These...
Tags
ETFs
From
ETF Channel
Agios to Present at the 39th Annual J.P. Morgan Healthcare Conference on Monday, January 11, 2021
January 05, 2021
From
GlobeNewswire News Releases
Analysts Anticipate 20% Gains Ahead For The Holdings of FBT
December 31, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Should Investors Consider These Top Biotech Stocks To Buy? 3 Names To Watch
December 23, 2020
Tags
Market News
From
Stockmarket.com
4 Reasons Agios' Oncology Deal Should Please Investors
December 22, 2020
Agios' newly revamped business strategy is an extreme departure from the company's original mission, but it's a great deal for shareholders.
Tags
RPRX
Market News
BMY
From
Motley Fool
82 Biggest Movers From Yesterday
December 22, 2020
Gainers Big Rock Partners Acquisition Corp. (NASDAQ: BRPA) shares surged 60.4% to close at $24.60 on Monday. Nantkwest Inc ...
Tags
QS
QTNT
LIXT
From
Benzinga
Noteworthy Monday Option Activity: OPY, DDOG, AGIO
December 21, 2020
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Oppenheimer Holdings Inc Class A (D (OPY), where a total volume of 885 contracts...
Tags
Stocks
From
Market News Video
12 Health Care Stocks Moving In Monday's Intraday Session
December 21, 2020
Gainers NantKwest (NASDAQ:NK) stock rose 57.4% to $16.15 during Monday's regular session. As of 12:31 EST, this ...
Tags
Market News
QURE
HJLI
From
Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
December 21, 2020
This unusual options alert can help traders track potentially big trading opportunities. Traders often look for circumstances when the ...
Tags
PFE
AGIO
BHC
From
Benzinga
55 Stocks Moving In Monday's Mid-Day Session
December 21, 2020
Gainers 500.com Limited (NYSE: WBAI) shares climbed 125.7% to $6.07 after the company announced a $23 million investment from ...
Tags
LIXT
FGF
CURO
From
Benzinga
Why Agios Pharmaceuticals Stock Is Soaring Today
December 21, 2020
Investors applauded the company's planned sale of its oncology portfolio.
Tags
AGIO
Market News
From
Motley Fool
Biopharma M&A Continues: Agios Sells Oncology Portfolio, NantKwest's Reverse Merger With ImmunityBio, Eyegate Picks Up Panoptes
December 21, 2020
M&A momentum in the biopharma space picked up pace, with a few more deals announced in the space this week. Agios To Divest ...
Tags
AGIO
Small Cap
NK
From
Benzinga
Thinking about buying stock in Agios Pharmaceuticals, Clovis Oncology, Aqua Metals, Cocrystal Pharma, or Luminar Technologies?
December 21, 2020
InvestorsObserver issues critical PriceWatch Alerts for AGIO, CLVS, AQMS, COCP, and LAZR.
From
PR Newswire
Agios Pharmaceuticals Stock Rockets On $2 Billion Oncology Business Sale
December 21, 2020
Agios Pharmaceuticals will sell its oncology business to Servier for up to $2 billion, the biotech company said Monday. In response, AGIO stock skyrocketed by double digits.
From
Investor's Business Daily
12 Health Care Stocks Moving In Monday's Pre-Market Session
December 21, 2020
Gainers Eyegate Pharmaceuticals (NASDAQ:EYEG) shares increased by 84.31% to $6.58 during Monday's pre-market ...
Tags
FGEN
Benzinga
Pre/Market Outlook
From
Benzinga
Agios to Focus on Developing and Commercializing Innovative Treatments for Genetically Defined Diseases and Sell Its Oncology Business to Servier for Up to $2 Billion Plus Royalties
December 21, 2020
From
GlobeNewswire News Releases
The Daily Biotech Pulse: Mesoblast Releases Mixed Data, MediWound Jumps On Distribution Deal, Kezar Life Sciences Rallies On Index Inclusion, Opiant Gets BARA Funding
December 15, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
NVTA
NGM
INBX
From
Benzinga
10 Health Care Stocks With Unusual Options Alerts In Today's Session
December 10, 2020
This unusual options alert can help traders discover the next big trading opportunities. Traders will search for circumstances when the ...
Tags
INO
Options
AMRN
From
Benzinga
71 Biggest Movers From Yesterday
December 09, 2020
Gainers Curis, Inc. (NASDAQ: CRIS) stock climbed 354.9% to close at $6.55 on Tuesday after the company announced ...
Tags
INFI
Pre/Market Outlook
News
From
Benzinga
12 Healthcare Stocks Moving In Tuesday's Intraday Session
December 08, 2020
Gainers Curis (NASDAQ:CRIS) stock increased by 337.15% to $6.29 during Tuesday's regular session. Trading volume for ...
Tags
Markets
PEN
CMD
From
Benzinga
52 Stocks Moving In Tuesday's Mid-Day Session
December 08, 2020
Gainers Curis, Inc. (NASDAQ: CRIS) stock jumped 323% to $6.09 after the company announced "positive" preliminary data ...
Tags
COUP
News
CGIX
From
Benzinga
The Daily Biotech Pulse: ASH Presentations, Axsome's Positive Midstage Readout, Follow-On Offerings
December 08, 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ...
Tags
FOLD
MRVI
AXSM
From
Benzinga
Agios Announces Updated Data from Phase 1 Study of Mitapivat, First-in-Class PKR Activator, in Sickle Cell Disease
December 07, 2020
From
GlobeNewswire News Releases
Week Ahead In Biotech: FDA To Decide On Emergency Use Of Pfizer's COVID Vaccine, Hematology Conference Presentations Pick Up Pace
December 06, 2020
Biotech stocks headed higher in the week ended Dec. 5 as broader market optimism pervaded into the sector. The sector also continued to ...
Tags
FDA
American Society of Hematology
IMRA
From
Benzinga
Agios Announces the Phase 3 ACTIVATE Trial of Mitapivat Achieved Its Primary Endpoint in Adults with Pyruvate Kinase Deficiency Who Are Not Regularly Transfused
December 01, 2020
From
GlobeNewswire News Releases
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.